Stay updated with breaking news from Ability Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
The growing demand in Australia Oncology market is projected to reach US$ 420.4 million by 2030, with an annual growth rate of 9%Wilmington, Delaware, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Australia Oncology Market value is estimated at US$ 230 million in 2023 and is expected to grow at a significant CAGR of over 9% over the forecast period of 2023-2030, according to the latest market report by RationalStat Market Definition, Market Scope, and Report Overview The oncology market is the segment of th
/PRNewswire/ -- The "Uterine Cancer Therapeutics & Diagnostics Market Research Report by Cancer Type, by Product, by Region - Global Forecast to 2027 -...
/PRNewswire/ -- The "Uterine Cancer Therapeutics & Diagnostics Market Research Report by Cancer Type, by Product, by Region - Global Forecast to 2027 -...
Australia Oncology Market Size Estimated to Reach $3,103 Million by 2026